vs
Offerpad Solutions Inc.（OPAD）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Offerpad Solutions Inc.的1.7倍（$197.9M vs $114.1M），REPLIGEN CORP同比增速更快（13.6% vs -34.5%），Offerpad Solutions Inc.自由现金流更多（$65.7M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -36.8%）
Offerpad Solutions Inc是美国知名房地产科技企业，专注于简化住宅房产交易流程，采用iBuyer模式直接向卖家收购房屋，完成翻新后挂牌出售，同时提供按揭、产权服务、灵活搬迁方案等配套服务，业务覆盖美国数十个州。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
OPAD vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.7倍
$114.1M
营收增速更快
RGEN
高出48.2%
-34.5%
自由现金流更多
OPAD
多$48.2M
$17.6M
两年增速更快
RGEN
近两年复合增速
-36.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.1M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | 7.0% | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | -34.5% | 13.6% |
| 净利润同比 | 49.1% | 143.9% |
| 每股收益（稀释后） | — | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OPADRGEN
| Q4 25 | $114.1M | $197.9M | ||
| Q3 25 | $132.7M | $188.8M | ||
| Q2 25 | $160.3M | $182.4M | ||
| Q1 25 | $160.7M | $169.2M | ||
| Q4 24 | $174.3M | $174.1M | ||
| Q3 24 | $208.1M | $154.9M | ||
| Q2 24 | $251.1M | $154.1M | ||
| Q1 24 | $285.4M | $151.3M |
净利润OPADRGEN
| Q4 25 | — | $13.3M | ||
| Q3 25 | $-11.6M | $14.9M | ||
| Q2 25 | $-10.9M | $14.9M | ||
| Q1 25 | $-15.1M | $5.8M | ||
| Q4 24 | $-17.3M | $-30.3M | ||
| Q3 24 | $-13.5M | $-654.0K | ||
| Q2 24 | $-13.8M | $3.3M | ||
| Q1 24 | $-17.5M | $2.1M |
毛利率OPADRGEN
| Q4 25 | 7.0% | 52.5% | ||
| Q3 25 | 7.0% | 53.2% | ||
| Q2 25 | 8.9% | 50.0% | ||
| Q1 25 | 6.5% | 53.6% | ||
| Q4 24 | 6.1% | 26.1% | ||
| Q3 24 | 8.2% | 50.0% | ||
| Q2 24 | 8.7% | 49.8% | ||
| Q1 24 | 7.9% | 49.5% |
营业利润率OPADRGEN
| Q4 25 | — | 9.0% | ||
| Q3 25 | -5.1% | 8.9% | ||
| Q2 25 | -4.9% | 7.6% | ||
| Q1 25 | -7.2% | 3.9% | ||
| Q4 24 | -7.8% | -17.7% | ||
| Q3 24 | -4.3% | -5.1% | ||
| Q2 24 | -3.9% | 1.0% | ||
| Q1 24 | -4.8% | 1.3% |
净利率OPADRGEN
| Q4 25 | — | 6.7% | ||
| Q3 25 | -8.7% | 7.9% | ||
| Q2 25 | -6.8% | 8.2% | ||
| Q1 25 | -9.4% | 3.4% | ||
| Q4 24 | -9.9% | -17.4% | ||
| Q3 24 | -6.5% | -0.4% | ||
| Q2 24 | -5.5% | 2.2% | ||
| Q1 24 | -6.1% | 1.4% |
每股收益（稀释后）OPADRGEN
| Q4 25 | — | $0.24 | ||
| Q3 25 | $-0.37 | $0.26 | ||
| Q2 25 | $-0.39 | $0.26 | ||
| Q1 25 | $-0.55 | $0.10 | ||
| Q4 24 | $-0.64 | $-0.55 | ||
| Q3 24 | $-0.49 | $-0.01 | ||
| Q2 24 | $-0.50 | $0.06 | ||
| Q1 24 | $-0.64 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $26.5M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $38.2M | $2.1B |
| 总资产 | $154.8M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资OPADRGEN
| Q4 25 | $26.5M | $767.6M | ||
| Q3 25 | $31.0M | $748.7M | ||
| Q2 25 | $22.6M | $708.9M | ||
| Q1 25 | $30.8M | $697.2M | ||
| Q4 24 | $43.0M | $757.4M | ||
| Q3 24 | $48.5M | $784.0M | ||
| Q2 24 | $56.9M | $809.1M | ||
| Q1 24 | $68.5M | $780.6M |
总债务OPADRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益OPADRGEN
| Q4 25 | $38.2M | $2.1B | ||
| Q3 25 | $39.9M | $2.1B | ||
| Q2 25 | $24.5M | $2.1B | ||
| Q1 25 | $34.2M | $2.0B | ||
| Q4 24 | $47.7M | $2.0B | ||
| Q3 24 | $64.7M | $2.0B | ||
| Q2 24 | $77.6M | $2.0B | ||
| Q1 24 | $88.1M | $2.0B |
总资产OPADRGEN
| Q4 25 | $154.8M | $2.9B | ||
| Q3 25 | $223.5M | $2.9B | ||
| Q2 25 | $268.0M | $2.9B | ||
| Q1 25 | $274.5M | $2.9B | ||
| Q4 24 | $313.1M | $2.8B | ||
| Q3 24 | $338.5M | $2.8B | ||
| Q2 24 | $406.6M | $2.9B | ||
| Q1 24 | $369.7M | $2.8B |
负债/权益比OPADRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $66.8M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $65.7M | $17.6M |
| 自由现金流率自由现金流/营收 | 57.6% | 8.9% |
| 资本支出强度资本支出/营收 | 0.9% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流OPADRGEN
| Q4 25 | $66.8M | $25.7M | ||
| Q3 25 | $40.0M | $48.1M | ||
| Q2 25 | $-13.5M | $28.6M | ||
| Q1 25 | $-10.2M | $15.0M | ||
| Q4 24 | $20.8M | $39.2M | ||
| Q3 24 | $39.6M | $49.3M | ||
| Q2 24 | $-54.4M | $42.2M | ||
| Q1 24 | $2.4M | $44.7M |
自由现金流OPADRGEN
| Q4 25 | $65.7M | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | $-13.6M | $21.5M | ||
| Q1 25 | $-11.2M | $11.4M | ||
| Q4 24 | $15.4M | $33.6M | ||
| Q3 24 | $38.7M | $42.3M | ||
| Q2 24 | $-54.4M | $37.4M | ||
| Q1 24 | $2.0M | $36.4M |
自由现金流率OPADRGEN
| Q4 25 | 57.6% | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | -8.5% | 11.8% | ||
| Q1 25 | -7.0% | 6.8% | ||
| Q4 24 | 8.9% | 19.3% | ||
| Q3 24 | 18.6% | 27.3% | ||
| Q2 24 | -21.7% | 24.3% | ||
| Q1 24 | 0.7% | 24.0% |
资本支出强度OPADRGEN
| Q4 25 | 0.9% | 4.1% | ||
| Q3 25 | 0.0% | 2.5% | ||
| Q2 25 | 0.1% | 3.9% | ||
| Q1 25 | 0.6% | 2.1% | ||
| Q4 24 | 3.1% | 3.2% | ||
| Q3 24 | 0.4% | 4.5% | ||
| Q2 24 | 0.0% | 3.1% | ||
| Q1 24 | 0.1% | 5.5% |
现金转化率OPADRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
